Kurokawa, T., Iinuma, T., Ebisu, H., Yanagidaira, T., Inaba, Y., Fujiwara, T., Hattori, Y., Fukazawa, T., Aoki, T., Koseki, H., Hanaoka, H., Hanazawa, T., Motohashi, S. (2026). A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. PLoS ONE. https://doi.org/10.1371/journal.pone.0342387